Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial
Bruix, Jordi, Dr, Qin, Shukui, Prof, Merle, Philippe, Prof, Granito, Alessandro, MD, Huang, Yi-Hsiang, Prof, Bodoky, György, MD, Pracht, Marc, MD, Yokosuka, Osamu, Prof, Rosmorduc, Olivier, Prof, Breder, Valeriy, MD, Gerolami, René, Prof, Masi, Gianluca, MD, Ross, Paul J, FRCP, Song, Tianqiang, PhD, Bronowicki, Jean-Pierre, Prof, Ollivier-Hourmand, Isabelle, MD, Kudo, Masatoshi, Prof, Cheng, Ann-Lii, Prof, Llovet, Josep M, Prof, Finn, Richard S, MD, LeBerre, Marie-Aude, MSc, Baumhauer, Annette, MD, Meinhardt, Gerold, MD, Han, Guohong, Prof
Published in The Lancet (British edition) (07.01.2017)
Published in The Lancet (British edition) (07.01.2017)
Get full text
Journal Article
Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial
Wilke, Hansjochen, Prof, Muro, Kei, MD, Van Cutsem, Eric, Prof, Oh, Sang-Cheul, Prof, Bodoky, György, Prof, Shimada, Yasuhiro, MD, Hironaka, Shuichi, MD, Sugimoto, Naotoshi, MD, Lipatov, Oleg, Prof, Kim, Tae-You, Prof, Cunningham, David, Prof, Rougier, Philippe, Prof, Komatsu, Yoshito, Prof, Ajani, Jaffer, Prof, Emig, Michael, MD, Carlesi, Roberto, MD, Ferry, David, Prof, Chandrawansa, Kumari, PhD, Schwartz, Jonathan D, MD, Ohtsu, Atsushi, MD
Published in The lancet oncology (01.10.2014)
Published in The lancet oncology (01.10.2014)
Get full text
Journal Article
Capecitabine and cisplatin with or without cetuximab for patients with previously untreated advanced gastric cancer (EXPAND): a randomised, open-label phase 3 trial
Lordick, Florian, Prof, Kang, Yoon-Koo, Prof, Chung, Hyun-Cheol, Prof, Salman, Pamela, MD, Oh, Sang Cheul, Prof, Bodoky, György, Prof, Kurteva, Galina, MD, Volovat, Constantin, MD, Moiseyenko, Vladimir M, Prof, Gorbunova, Vera, Prof, Park, Joon Oh, MD, Sawaki, Akira, MD, Celik, Ilhan, Prof, Götte, Heiko, PhD, Melezínková, Helena, MD, Moehler, Markus, Prof
Published in The lancet oncology (01.05.2013)
Published in The lancet oncology (01.05.2013)
Get full text
Journal Article
Outcomes of sequential treatment with sorafenib followed by regorafenib for HCC: Additional analyses from the phase III RESORCE trial
Finn, Richard S., Merle, Philippe, Granito, Alessandro, Huang, Yi-Hsiang, Bodoky, György, Pracht, Marc, Yokosuka, Osamu, Rosmorduc, Olivier, Gerolami, René, Caparello, Chiara, Cabrera, Roniel, Chang, Charissa, Sun, Weijing, LeBerre, Marie-Aude, Baumhauer, Annette, Meinhardt, Gerold, Bruix, Jordi
Published in Journal of hepatology (01.08.2018)
Published in Journal of hepatology (01.08.2018)
Get full text
Journal Article
Cetuximab and Chemotherapy as Initial Treatment for Metastatic Colorectal Cancer
Van Cutsem, Eric, Köhne, Claus-Henning, Hitre, Erika, Zaluski, Jerzy, Chang Chien, Chung-Rong, Makhson, Anatoly, D'Haens, Geert, Pintér, Tamás, Lim, Robert, Bodoky, György, Roh, Jae Kyung, Folprecht, Gunnar, Ruff, Paul, Stroh, Christopher, Tejpar, Sabine, Schlichting, Michael, Nippgen, Johannes, Rougier, Philippe
Published in The New England journal of medicine (02.04.2009)
Published in The New England journal of medicine (02.04.2009)
Get full text
Journal Article
Current therapy of advanced colorectal cancer according to RAS/RAF mutational status
Lakatos, Gábor, Köhne, Claus-Henning, Bodoky, György
Published in Cancer and metastasis reviews (01.12.2020)
Published in Cancer and metastasis reviews (01.12.2020)
Get full text
Journal Article
Bevacizumab plus oxaliplatin-based chemotherapy as adjuvant treatment for colon cancer (AVANT): a phase 3 randomised controlled trial
de Gramont, Aimery, Prof, Van Cutsem, Eric, Prof, Schmoll, Hans-Joachim, Prof, Tabernero, Josep, MD, Clarke, Stephen, Prof, Moore, Malcolm J, Prof, Cunningham, David, Prof, Cartwright, Thomas H, MD, Hecht, J Randolph, Prof, Rivera, Fernando, MD, Im, Seock-Ah, Prof, Bodoky, György, Prof, Salazar, Ramon, Prof, Maindrault-Goebel, Frédérique, MD, Shacham-Shmueli, Einat, MD, Bajetta, Emilio, Prof, Makrutzki, Martina, MD, Shang, Aijing, MD, André, Thierry, MD, Hoff, Paulo M, Prof
Published in The lancet oncology (01.12.2012)
Published in The lancet oncology (01.12.2012)
Get full text
Journal Article
Randomized, Phase III Trial of Panitumumab With Infusional Fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX4) Versus FOLFOX4 Alone As First-Line Treatment in Patients With Previously Untreated Metastatic Colorectal Cancer: The PRIME Study
DOUILLARD, Jean-Yves, SIENA, Salvatore, RIVERA, Fernando, KOCAKOVA, Ilona, RUFF, Paul, BLASINSKA-MORAWIEC, Maria, SMAKAL, Martin, CANON, Jean-Luc, ROTHER, Mark, OLINER, Kelly S, WOLF, Michael, GANSERT, Jennifer, CASSIDY, James, TABERNERO, Josep, BURKES, Ronald, BARUGEL, Mario, HUMBLET, Yves, BODOKY, György, CUNNINGHAM, David, JASSEM, Jacek
Published in Journal of clinical oncology (01.11.2010)
Published in Journal of clinical oncology (01.11.2010)
Get full text
Journal Article
Prognostic Role of KRAS and BRAF in Stage II and III Resected Colon Cancer: Results of the Translational Study on the PETACC-3, EORTC 40993, SAKK 60-00 Trial
ROTH, Arnaud D, TEJPAR, Sabine, ARANDA, Enrique, NORDLINGER, Bernard, CISAR, Laura, LABIANCA, Roberto, CUNNINGHAM, David, VAN CUTSEM, Eric, BOSMAN, Fred, DELORENZI, Mauro, PU YAN, FIOCCA, Roberto, KLINGBIEL, Dirk, DIETRICH, Daniel, BIESMANS, Bart, BODOKY, György, BARONE, Carlo
Published in Journal of clinical oncology (20.01.2010)
Published in Journal of clinical oncology (20.01.2010)
Get full text
Journal Article
Exposure-Response Analyses of Ramucirumab from Two Randomized, Phase III Trials of Second-line Treatment for Advanced Gastric or Gastroesophageal Junction Cancer
Tabernero, Josep, Ohtsu, Atsushi, Muro, Kei, Van Cutsem, Eric, Oh, Sang Cheul, Bodoky, György, Shimada, Yasuhiro, Hironaka, Shuichi, Ajani, Jaffer A, Tomasek, Jiri, Safran, Howard, Chandrawansa, Kumari, Hsu, Yanzhi, Heathman, Michael, Khan, Azhar, Ni, Lan, Melemed, Allen S, Gao, Ling, Ferry, David, Fuchs, Charles S
Published in Molecular cancer therapeutics (01.10.2017)
Published in Molecular cancer therapeutics (01.10.2017)
Get full text
Journal Article
Randomized, Placebo-Controlled, Phase III Study of First-Line Oxaliplatin-Based Chemotherapy Plus PTK787/ZK 222584, an Oral Vascular Endothelial Growth Factor Receptor Inhibitor, in Patients With Metastatic Colorectal Adenocarcinoma
HECHT, J. Randolph, TRARBACH, Tanja, CHEN, Bee-Lian, JALAVA, Tarja, MEINHARDT, Gerold, LAURENT, Dirk, LEBWOHL, David, KERR, David, HAINSWORTH, John D, MAJOR, Pierre, JÄGER, Elke, WOLFF, Robert A, LLOYD-SALVANT, Katherine, BODOKY, György, PENDERGRASS, Kelly, BERG, William
Published in Journal of clinical oncology (20.05.2011)
Published in Journal of clinical oncology (20.05.2011)
Get full text
Journal Article
Cediranib With mFOLFOX6 Versus Bevacizumab With mFOLFOX6 As First-Line Treatment for Patients With Advanced Colorectal Cancer: A Double-Blind, Randomized Phase III Study (HORIZON III)
SCHMOLL, Hans-Joachim, CUNNINGHAM, David, SALAZAR, Ramon, BARKER, Peter, MOOKERJEE, Bijoyesh, ROBERTSON, Jane, VAN CUTSEM, Eric, SOBRERO, Alberto, KARAPETIS, Christos S, ROUGIER, Philippe, KOSKI, Sheryl L, KOCAKOVA, Ilona, BONDARENKO, Igor, BODOKY, György, MAINWARING, Paul
Published in Journal of clinical oncology (10.10.2012)
Published in Journal of clinical oncology (10.10.2012)
Get full text
Journal Article
Baseline carcinoembryonic antigen as a predictive factor of ramucirumab efficacy in RAISE, a second-line metastatic colorectal carcinoma phase III trial
Yoshino, Takayuki, Obermannová, Radka, Bodoky, György, Garcia-Carbonero, Rocio, Ciuleanu, Tudor, Portnoy, David C, Kim, Tae Won, Hsu, Yanzhi, Ferry, David, Nasroulah, Federico, Tabernero, Josep
Published in European journal of cancer (1990) (01.06.2017)
Published in European journal of cancer (1990) (01.06.2017)
Get full text
Journal Article
Randomized Phase III Trial Comparing Biweekly Infusional Fluorouracil/Leucovorin Alone or With Irinotecan in the Adjuvant Treatment of Stage III Colon Cancer: PETACC-3
VAN CUTSEM, Eric, LABIANCA, Roberto, MINI, Enrico, GREIL, Richard, DI COSTANZO, Francesco, COLLETTE, Laurence, CISAR, Laura, XIAOXI ZHANG, KHAYAT, David, BOKEMEYER, Carsten, ROTH, Arnaud D, CUNNINGHAM, David, BODOKY, György, BARONE, Carlo, ARANDA, Enrique, NORDLINGER, Bernard, TOPHAM, Claire, TABERNERO, Josep, ANDRE, Thierry, SOBRERO, Alberto F
Published in Journal of clinical oncology (01.07.2009)
Published in Journal of clinical oncology (01.07.2009)
Get full text
Journal Article
Predicting mortality and adverse events in patients with advanced pancreatic cancer treated with palliative gemcitabine-based chemotherapy in a multicentre phase III randomized clinical trial: the APC-SAKK risk scores
Gargiulo, Piera, Dietrich, Daniel, Herrmann, Richard, Bodoky, György, Ruhstaller, Thomas, Scheithauer, Werner, Glimelius, Bengt, Berardi, Simona, Pignata, Sandro, Brauchli, Peter
Published in Therapeutic advances in medical oncology (01.01.2019)
Published in Therapeutic advances in medical oncology (01.01.2019)
Get full text
Journal Article
Liposomal Irinotecan + 5-FU/LV in Metastatic Pancreatic Cancer: Subgroup Analyses of Patient, Tumor, and Previous Treatment Characteristics in the Pivotal NAPOLI-1 Trial
Macarulla Mercadé, Teresa, Chen, Li-Tzong, Li, Chung-Pin, Siveke, Jens T, Cunningham, David, Bodoky, György, Blanc, Jean-Frédéric, Lee, Kyung-Hun, Dean, Andrew, Belanger, Bruce, Wang-Gillam, Andrea
Published in Pancreas (01.01.2020)
Published in Pancreas (01.01.2020)
Get more information
Journal Article
Gemcitabine Plus Capecitabine Compared With Gemcitabine Alone in Advanced Pancreatic Cancer: A Randomized, Multicenter, Phase III Trial of the Swiss Group for Clinical Cancer Research and the Central European Cooperative Oncology Group
HERRMANN, Richard, BODOKY, György, KDHNE, Claus-Henning, MINGRONE, Walter, STEMMER, Salomon M, TAMAS, Karin, KORNEK, Gabriela V, KOEBERLE, Dieter, CINA, Susanne, BERNHARD, Jürg, DIETRICH, Daniel, SCHEITHAUER, Werner, RUHSTALLER, Thomas, GLIMELIUS, Bengt, BAJETTA, Emilio, SCHÜLLER, Johannes, SALETTI, Piercarlo, BAUER, Jean, FIGER, Arie, PESTALOZZI, Bernhard
Published in Journal of clinical oncology (01.06.2007)
Published in Journal of clinical oncology (01.06.2007)
Get full text
Journal Article
Prognostic Factor Analysis of Overall Survival in Gastric Cancer from Two Phase III Studies of Second-line Ramucirumab (REGARD and RAINBOW) Using Pooled Patient Data
Fuchs, Charles S, Muro, Kei, Tomasek, Jiri, Van Cutsem, Eric, Cho, Jae Yong, Oh, Sang-Cheul, Safran, Howard, Bodoky, György, Chau, Ian, Shimada, Yasuhiro, Al-Batran, Salah-Eddin, Passalacqua, Rodolfo, Ohtsu, Atsushi, Emig, Michael, Ferry, David, Chandrawansa, Kumari, Hsu, Yanzhi, Sashegyi, Andreas, Liepa, Astra M, Wilke, Hansjochen
Published in Journal of gastric cancer (01.06.2017)
Published in Journal of gastric cancer (01.06.2017)
Get full text
Journal Article
Tumor Response and Symptom Palliation from RAINBOW, a Phase III Trial of Ramucirumab Plus Paclitaxel in Previously Treated Advanced Gastric Cancer
Cascinu, Stefano, Bodoky, György, Muro, Kei, Van Cutsem, Eric, Oh, Sang Cheul, Folprecht, Gunnar, Ananda, Sumitra, Girotto, Gustavo, Wainberg, Zev A., Miron, Maria Luisa Limon, Ajani, Jaffer, Wei, Ran, Liepa, Astra M., Carlesi, Roberto, Emig, Michael, Ohtsu, Atsushi
Published in The oncologist (Dayton, Ohio) (01.03.2021)
Published in The oncologist (Dayton, Ohio) (01.03.2021)
Get full text
Journal Article